Perfil
Sarah C.
DiSalvatore worked as Vice President-Clinical Operations at Beacon Therapeutics (USA), Inc. from 2021 to 2023.
Prior to that, she worked as Associate Vice President-Clinical Operations at Rocket Pharmaceuticals, Inc.
Antiguos cargos conocidos de Sarah DiSalvatore.
Empresas | Cargo | Fin |
---|---|---|
APPLIED GENETIC TECHNOLOGIES CORPORATION | Director Técnico/Científico/I+D | 01/04/2023 |
ROCKET PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
ROCKET PHARMACEUTICALS, INC. | Health Technology |
Empresas privadas | 1 |
---|---|
Beacon Therapeutics (USA), Inc.
Beacon Therapeutics (USA), Inc. Pharmaceuticals: GenericHealth Technology Applied Genetic Technologies Corp. is a clinical stage biotechnology company, which engages in the usage of a gene therapy platform to develop transformational genetic therapies for patients suffering from rare and debilitating diseases. The firm also focuses on conducting clinical trials in the field of ophthalmology, optogenetics, adrenoleukodystrophy, and otology. The company was founded by Richard Jude Samulski, Nicholas Muzyczka, William W. Hauswirth, Terence R. Flotte, and Barry J. Byrne on January 19, 1999 and is headquartered in Alachua, FL. | Health Technology |
- Bolsa de valores
- Insiders
- Sarah DiSalvatore